Amylyx Pharmaceuticals
AMLX
$34.49
+2.01%
Related headlines
AMLX price trend
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Amylyx Pharmaceuticals's 12-month outlook, with a consensus price target around $42.36 and implied upside of +22.8% versus the current price.
Average Target
$42.36
0 analysts
Implied Upside
+22.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$20 - $57
Analyst target range
AMLX Technical Analysis
Beta
-0.20
-0.20x market volatility
Max Drawdown
-30.6%
Largest decline past year
52-Week Range
$10-$41
Price range past year
Annual Return
+245.6%
Cumulative gain past year
| Period | AMLX Return | S&P 500 |
|---|---|---|
| 1m | +71.0% | +1.0% |
| 3m | +141.0% | +1.1% |
| 6m | +149.0% | +13.8% |
| 1y | +245.6% | +19.5% |
| ytd | +202.0% | +12.2% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
Valuation Analysis: Is AMLX Overvalued?
PE
-7.9x
Latest Quarter
vs. Historical
N/A
5-Year PE Range 17x~59x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
-6.4x
Enterprise Value Multiple